Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent

P Joling1, L J Bakker, J A Van Strijp

  • 1Department of Pathology, University Hospital, Utrecht, The Netherlands.

Insights

Human immunodeficiency virus type 1 (HIV-1) binds to follicular dendritic cells (FDC) in fresh serum. This binding is dependent on complement component C3 and enhanced by antibodies from infected patients.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Follicular dendritic cells (FDC) play a crucial role in adaptive immunity.
  • Understanding how viruses interact with FDC is vital for comprehending viral pathogenesis and immune evasion strategies.

Purpose of the Study:

  • To investigate the in vitro binding of human immunodeficiency virus type 1 (HIV-1) to FDC.
  • To elucidate the role of serum components, including complement factors and antibodies, in mediating HIV-1 binding to FDC.

Main Methods:

  • Flow cytometry and fluorescence microscopy were used to quantify HIV-1 binding to FDC.
  • Immunogold electron microscopy provided ultrastructural evidence of viral binding.
  • Experiments utilized serum from healthy donors and HIV-1-infected patients, with and without specific complement factors (C3, C5).

Main Results:

  • HIV-1 binding to FDC was significantly enhanced in the presence of fresh serum, particularly from HIV-1-infected patients.
  • Binding was dependent on complement component C3 but not C5.
  • Anti-HIV-1 antibodies enhanced binding but were insufficient to mediate it alone.
  • Most bound HIV-1 virions were located extracellularly on FDC, contrasting with intracellular localization on blood mononuclear cells.

Conclusions:

  • HIV-1 virions adhere to FDC in vitro via a mechanism dependent on complement component C3.
  • Antibodies from HIV-1-infected individuals can enhance this binding process.

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...